Gastroenterology

Acute Cholecystitis

Acute cholecystitis requires prompt distinction from alternative biliary and nonbiliary causes of right upper-quadrant pain, confirmation with imaging, assessment for sepsis or ductal complications, and timely source control. The supplied results do not contain disease-specific diagnostic or management guidance.

Clinical question: How should physicians diagnose, risk-stratify, and manage suspected acute cholecystitis?

Updated August 20, 20261 minute readGastroenterology and General Surgery

Evidence limitation

No usable disease-specific evidence was supplied

The retrieved sources do not address acute cholecystitis.

The supplied results concern colchicine, sitagliptin, finerenone, pulmonary embolism, peripheral artery disease, heart failure, diagnostic-test methodology, artificial intelligence, and guideline-development processes. None provides evidence specific to the diagnosis, severity grading, imaging sequence, antibiotics, timing of cholecystectomy, gallbladder drainage, choledocholithiasis evaluation, or post-procedural management of acute cholecystitis.

Because the requested article requires citations for diagnostic, pharmacologic, procedural, and prognostic claims and restricts use to supplied search results, a substantive point-of-care review would require unsupported assertions. No disease-specific recommendations, thresholds, doses, or algorithms are provided here.

Do not use the included colchicine, sitagliptin, or finerenone prescribing information to guide treatment of acute cholecystitis; those sources address unrelated indications.dailymed nlm nih+2dailymed nlm nihThese highlights do not include all the information needed to use colchicine safely and effectively. See full prescribing information for Colchicine Tablets, USP. Colchicine Tablets, USP, for oral use Initial U.S. Approval: 1961 dailymed nlm nihThese highlights do not include all the information needed to use JANUVIA safely and effectively. See full prescribing information for JANUVIA. JANUVIA® (sitagliptin) TabletsInitial U.S. Approval: 2006 dailymed nlm nihThese highlights do not include all the information needed to use KERENDIA safely and effectively. See full prescribing information for KERENDIA. KERENDIA (finerenone) tablets, for oral use Initial U.S. Approval: 2021
The diagnostic-test and machine-learning literature supplied is not evidence for evaluating or treating acute cholecystitis.Nature+3NatureClinical validation of an AI-based blood testing device for diagnosis and prognosis of acute infection and sepsis | Nature Medicine NatureDevelopment and validation of prognostic machine learning models for short- and long-term mortality among acutely admitted patients based on blood tests | Scientific Reports NatureA unified framework for diagnostic test development and evaluation during outbreaks of emerging infections NatureThe hidden risk of round numbers and sharp thresholds in clinical practice | npj Digital Medicine

Relevance of supplied evidence to acute cholecystitis
Source group	Relevance	Permissible use for this topic
Drug labeling for colchicine, sitagliptin, and finerenone	Unrelated indications and safety information.dailymed nlm nih+2dailymed nlm nihThese highlights do not include all the information needed to use colchicine safely and effectively. See full prescribing information for Colchicine Tablets, USP. Colchicine Tablets, USP, for oral use Initial U.S. Approval: 1961 dailymed nlm nihThese highlights do not include all the information needed to use JANUVIA safely and effectively. See full prescribing information for JANUVIA. JANUVIA® (sitagliptin) TabletsInitial U.S. Approval: 2006 dailymed nlm nihThese highlights do not include all the information needed to use KERENDIA safely and effectively. See full prescribing information for KERENDIA. KERENDIA (finerenone) tablets, for oral use Initial U.S. Approval: 2021	None for acute cholecystitis diagnosis or treatment.
Cardiovascular and pulmonary guidelines	Unrelated clinical conditions.AHA Journals+3AHA Journals2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/ ...AHA Journals2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/ ...AHA Journals2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ...AHA JournalsACC/AHA Guidelines for the Management of Patients With ...	None for acute cholecystitis.
Diagnostic and artificial-intelligence studies	General methodology or infection/sepsis test validation, not biliary disease management.Nature+3NatureClinical validation of an AI-based blood testing device for diagnosis and prognosis of acute infection and sepsis \| Nature Medicine NatureDevelopment and validation of prognostic machine learning models for short- and long-term mortality among acutely admitted patients based on blood tests \| Scientific Reports NatureA unified framework for diagnostic test development and evaluation during outbreaks of emerging infections NatureThe hidden risk of round numbers and sharp thresholds in clinical practice \| npj Digital Medicine	None for disease-specific clinical recommendations.

Common questions

What evidence is needed to create a point-of-care review of acute cholecystitis?

Relevant sources should include a current acute cholecystitis guideline, evidence for ultrasonography and second-line imaging, antimicrobial recommendations, trials or systematic reviews on early cholecystectomy and gallbladder drainage, and guidance for suspected common bile duct stones or cholangitis. None was supplied.

Can this source set support antibiotic selection or procedural timing?

No. The available prescribing information concerns unrelated drugs, and no supplied source provides acute cholecystitis antibiotic regimens, renal adjustments, source-control indications, or timing evidence.dailymed nlm nih+2dailymed nlm nihThese highlights do not include all the information needed to use colchicine safely and effectively. See full prescribing information for Colchicine Tablets, USP. Colchicine Tablets, USP, for oral use Initial U.S. Approval: 1961 dailymed nlm nihThese highlights do not include all the information needed to use JANUVIA safely and effectively. See full prescribing information for JANUVIA. JANUVIA® (sitagliptin) TabletsInitial U.S. Approval: 2006 dailymed nlm nihThese highlights do not include all the information needed to use KERENDIA safely and effectively. See full prescribing information for KERENDIA. KERENDIA (finerenone) tablets, for oral use Initial U.S. Approval: 2021